Search

everythinglearnresearchcommunity

for

Search:↓

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

Some breast cancer chemotherapy can cause permanent hair loss.

Cooling can protect hair follicles from chemotherapy damage by reducing drug uptake.

Some patients' hair grew back black and white after chemotherapy.

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

Some breast cancer treatments caused long-term hair loss in women, similar to a condition called alopecia areata.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Many adult women experience unexplained excessive hair shedding, often starting before age 40.

A scalp-cooling system effectively prevents hair loss in breast cancer patients treated with eribulin.

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

Oral minoxidil may effectively treat hair loss from chemotherapy.

Dutasteride may help shrink prostate cancer tumors.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Vitamin C was found to effectively treat prickly heat in children.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

Recognizing trichoscopic features is crucial for diagnosing various hair loss conditions.

More research is needed to understand chemotherapy-induced hair loss and its phases.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Combining irinotecan and cetuximab is effective for some metastatic colorectal cancer patients but often causes manageable skin issues.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Copper-doxorubicin nanoparticles effectively treat tumors with less toxicity.

Etoposide is effective in treating several cancers, especially small cell lung cancer, with acceptable side effects.

Guilu Erxian Glue may help reduce chemotherapy side effects like weight loss and heart stress.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.